European Home Mechanical Ventilation Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

37 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-08-31

Study Completion Date

2019-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The European Home Mechanical Ventilation Registry (EHMVR) will enable a thorough evaluation of HMV by documenting the characteristics of HMV patients and their treatment. This will facilitate a prospective, observational study to identify the primary indications for HMV, describe patterns of HMV use in European countries, and characterize changes in the initiation and utilization of HMV over time. The registry will target all adult individuals who have an indication for HMV. In the EHMVR, patient data from routine clinical care will be documented using an electronic case report form (eCRF). The eCRF will record: patient demographic data; diagnostic information (including primary diagnosis, 6-minute walk time, the presence of depression, and quality of life); blood gases; ventilation treatment (including type of ventilator, modes and settings, interfaces used); follow-up data (including failure rates, side effects, technical issues). An initial Pilot Phase will be launched with the aim to enrol at least 200 patients over a 6-month period to determine the feasibility of the registry. Steering committee members and their institutions will be the main participants in the Pilot Phase. After completion of the Pilot Phase, the registry will be expanded across Europe with the goal of enrolling approximately 10,000 patients over 5 years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

NCT00292539

Atrial Fibrillation Bradycardia Heart Block +1 more

COMPLETED

Meir Medical Center Home Monitoring Clinic Registry

NCT01516112

Patients Implanted With an ICD or CRTD.

UNKNOWN

Ability of Home Monitoring® to Detect and Manage the Inappropriate Diagnoses in Implantable Cardioverter Defibrillators.

NCT01594112

ICD Sudden Cardiac Death Ventricular Fibrillation +2 more

COMPLETED

Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD

NCT02318550

MRI Scans Magnetic Resonance Imaging Pacemaker +1 more

COMPLETED

AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT

NCT04225520

Left Ventricular Dyssynchrony Heart Failure Cardiomyopathy, Dilated +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The data (baseline and follow-up) should be collected as part of routine clinical care. In clinical practice, after HMV initiation, the first control examination (follow-up number one) with nocturnal diagnostics should take place within the first 4-8 weeks. Annual follow-up is required, and it is recommended that subsequent control visits should be performed 1-2 times a year. Each patient will be included for 5 years (total duration of the registry).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive Amyotrophic Lateral Sclerosis Spinal Cord Injury Muscular Dystrophies Obesity Hypoventilation Syndrome Kyphoscoliosis Congenital Central Hypoventilation Syndrome Duchenne Muscular Dystrophy Myopathies Myotonic Dystrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged ≥18 years with an indication to receive HMV as part of routine clinical care
* Patient is able to fully understand the study information and is willing to give informed consent
* Patient, or the patient's legal guardian, signing the consent form

Eligible Sex

ALL

Accepts Healthy Volunteers

No